Ionica Sciences
A better way to test for Lyme disease
Analytics
Raised to Date: $0
Aggregate Commitments $
SeedInvest
09/10/2020
11/08/2020
$25,000
$750,000
$1,000
Convertible Note
RegCF / RegD 506(C)
Seed
$5,500,000
20%
Weekly Commitments $
11/08/2020
0%
0%
$0
Ithaca, New York
Healthcare & Pharmaceuticals
Medtech
B2B2C
Medium
High
Ionica Sciences, with a $5.5 million valuation cap, is raising crowdfunding on SeedInvest. The company’s technology enables direct detection of Lyme disease with the help of a blood test. Lyme disease is difficult to diagnose, but it becomes easily detectable with the IonLyme Test of Ionica Sciences. The test detects a special protein released into the blood by the bacteria causing the disease. Omar Green, Joel Tabb, and Dean Koch founded Ionica Sciences in 2013. The proceeds of the current crowdfunding round, with a minimum raise of $25,000 and a maximum raise of $750,000, will be used for salaries, research and development, operations, and commercial lab transfer. Ionica Sciences has filed an international patent application under the PCT and received three SBIR contracts from the Department of Defense and the Defense Health Agency.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-325,300 |
$-40,643 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$139,160 |
$300,890 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$232,502 |
$375,663 |
|
Short-Term Debt |
$293,928 |
$43,544 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$293,928 |
$268,544 |
Ratings
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals
Millennial Fertility Co. on NetCapital
The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…
Biopact on Equifund CFP
Biopact has been selected as a “Deal to Watch” by KingsCrowd. This distinction is reserved for deals selected…
Neurotez Inc. on NetCapital
Neurotez has been selected as a “Deal To Watch” by KingsCrowd. This distinction is reserved for deals selected…